Biventricular mechanical circulatory support. History and current state of the problem-Reference-Cited by-同舟云学术

Biventricular mechanical circulatory support. History and current state of the problem

Published:2023-07-15 Issue:2 Volume:25 Page:49-56
ISSN:2412-6160
Container-title:Russian Journal of Transplantology and Artificial Organs
language:
Short-container-title:RJTAO

Author:

Zhulkov M. O.¹,Sirota D. A.¹,Khvan D. S.¹,Makaev A. G.¹,Agaeva H. A.¹,Zykov I. S.¹,Fomichev A. V.¹,Poveschenko O. V.¹,Surovtseva M. A.¹,Chernyavsky A. M.¹

Affiliation:

1. Meshalkin National Medical Research Center

Abstract

Medical management of end-stage chronic heart failure (HF) has evolved significantly over the past few decades. With a better understanding of the pathophysiology of HF, new pharmacological agents have been synthesized. However, survival in this cohort of patients with medical treatment remains extremely low. This has stimulated the development of surgical methods of treatment. Recent technological advances in the development of mechanical circulatory assist devices have made possible a single-stage implantation of two centrifugal pumps as an alternative to a total artificial heart. Today ventricular assist devices can be implanted to provide both univentricular and biventricular support depending on the severity of hemodynamic disorders, target organ damage, likelihood of recovery and heart transplantation.

Publisher

V.I. Shimakov Federal Research Center of Transplantology and Artificial Organs

Subject

Transplantation,Immunology and Allergy

Reference63 articles.

1. Hunt SA, Abraham WT, Chin MH, Feldman AM, Francis GS, Ganiats TG et al. American College of Cardiology; American Heart Association Task Force on Practice Guidelines; American College of Chest Physicians; International Society for Heart and Lung Transplantation; Heart Rhythm Society. ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure): developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: endorsed by the Heart Rhythm Society. Circulation. 2005; 112 (12): e154–235. doi: 10.1161/CIRCULATIONAHA.105.167586.

2. Kirklin JK, Naftel DC, Pagani FD, Kormos RL, Stevenson LW, Blume ED et al. Seventh INTERMACS annual report: 15,000 patients and counting. J Heart Lung Transplant. 2015; 34 (12): 1495–1504. doi: 10.1016/j.healun.2015.10.003.

3. Mehra MR, Park MH, Landzberg MJ, Lala A, Waxman AB. Right heart failure: toward a common language. Pulm Circ. 2013; 3 (4): 963–967. doi: 10.1086/674750.

4. Kormos RL. The right heart failure dilemma in the era of left ventricular assist devices. J Heart Lung Transplant. 2014; 33 (2): 134–135. doi: 10.1016/j.healun.2013.12.019.

5. Takeda K, Naka Y, Yang JA, Uriel N, Colombo PC, Jorde UP et al. Outcome of unplanned right ventricular assist device support for severe right heart failure after implantable left ventricular assist device insertion. J Heart Lung Transplant. 2014; 33 (2): 141–148. doi: 10.1016/j.healun.2013.06.025.